Jennifer A. Surtees has long been dedicated to studying genome stability and boosting community involvement in research. With a new National Institutes of Health (NIH) grant, she’ll get to do both.
A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results